Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1996
12/25/1996CN1138853A 1,5-benzodiazepine derivatives useful as CCK or gastrin antagonists
12/25/1996CN1138851A Metalloproteinase inhibitors
12/25/1996CN1138826A Microgranules of 5-nitro imidazole derivatives
12/25/1996CN1138588A Phosphonomonoester nucleic acids, process for their preparation, and their use
12/25/1996CN1138585A Mixed micelles
12/25/1996CN1138583A 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones
12/25/1996CN1138582A heteroatom-comtaining benzocyclopentane-oxazolidinones
12/25/1996CN1138581A Substituted biphenyl sulfonamide endothelin antagonists
12/25/1996CN1138575A 4-aminobenzoylguanidine derivatives
12/25/1996CN1138572A Application of Ubimec medicinal compsn. or containing ubimec for treatment virus hepatitis
12/25/1996CN1138459A Recovering medicine for CHD
12/25/1996CN1138458A Treatment and prevention of prostatic cancer
12/25/1996CN1138457A Medicine for treatment of psoriasis
12/25/1996CN1033646C 4,13-dioxy-bicyclo(8,2,1)tridecylenone derivative, its prepn. method and its intermediate product and said compound-contained medicament
12/25/1996CN1033645C Oleandomycin oximes, prepn. and use thereof
12/25/1996CN1033644C 3-substituent methyl-2,3-dihydroimidazo |1,2-C¨ quinazoline derivant, its prepn. and application
12/25/1996CN1033641C Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-Yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride
12/25/1996CN1033640C 2-substituted-5-substituted-1, 3-oxathiolanes with antiviral properties
12/25/1996CN1033639C Benzoquinonyl-containing thiazolidine compound preparing process
12/25/1996CN1033638C Novel alpha-mannosidase and fucosidase inhibitors
12/24/1996US5587505 Triterpene derivatives and endothelin-receptor antagonists containing the same
12/24/1996US5587497 19-nor-vitamin D compounds
12/24/1996US5587496 15,15-dialkyl-substituted derivatives of estradiol
12/24/1996US5587495 4-substituted anthracyclinones and anthracycline glycosides and the process for preparing them
12/24/1996US5587493 Process for preparing taxoids
12/24/1996US5587485 Catalytic oxidation of the corresponding alkyl substituted benzene compound
12/24/1996US5587481 Preparation of (S)-decahydroisoquinoline-3-carboxylic acid t-butylamide
12/24/1996US5587480 Treating hiv and hepatitis virus infections
12/24/1996US5587479 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
12/24/1996US5587476 Fullerene derivatives, method of synthesizing them and their use
12/24/1996US5587473 Blocking; condensation; deblocking
12/24/1996US5587469 Oligonucleotides containing N-2 substituted purines
12/24/1996US5587460 Controller of cell differentiation; immunology
12/24/1996US5587402 Regression of mammalian leukemia cell tumors
12/24/1996US5587400 Using an organoaluminum complex
12/24/1996US5587398 Affinity for serotonergic neurons; treating nervous system disorder; lipophilic
12/24/1996US5587397 Reduction of elevated blood lactate using twice-daily dichloroacetate
12/24/1996US5587395 Applying to wound or burn to prevent free-radical damage
12/24/1996US5587391 Treating ocular hypertension
12/24/1996US5587389 Substituted heteroarylaklylthiopyridines for controlling helicobacter bacteria
12/24/1996US5587388 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
12/24/1996US5587386 Optically active pyridonecarboxylic acid derivatives
12/24/1996US5587384 Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity
12/24/1996US5587382 Antitumor agents
12/24/1996US5587381 Repeated steps of administration of opiate atagonist and the subject's taking of the opiate and withholding of antagonist for a period when subject cannot take opiates until behavior is extinguished
12/24/1996US5587380 Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyrimidines which are pharmacologically active CNS compounds
12/24/1996US5587377 Terazosin crystalline polymorph and pharmaceutical compositions thereof
12/24/1996US5587376 Antiischemic agents, decongestants
12/24/1996US5587375 Azepinone compounds useful in the inhibition of ACE and NEP
12/24/1996US5587374 Bactericides treating infections
12/24/1996US5587373 Elastase inhibitors
12/24/1996US5587371 Effective for treating hypoxic areas of solid neoplasms
12/24/1996US5587369 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/24/1996US5587368 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injury
12/24/1996US5587367 Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol
12/24/1996US5587364 Acetylated mannan
12/24/1996US5587363 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
12/24/1996US5587362 L-nucleosides
12/24/1996US5587358 Potentiators of antimicrobial activity
12/24/1996US5587306 Dna sequences
12/24/1996US5587176 Methods of using hesperetin for sebum control and treatment of acne
12/24/1996US5587171 Synergistic oxidation resistant mixture
12/24/1996US5587169 Cosmetic or pharmaceutical composition comprising an alkyl carbamate as hydrating agent
12/24/1996US5587161 Prodrugs for antibody directed enzyme prodrug therapy
12/24/1996US5587150 Sunscreen agents
12/24/1996US5587149 Polyethylene glycol in oil emulsion in gelatin capsules
12/24/1996US5587143 Adsorbed on surface
12/24/1996CA2179680A1 Thiopyran derivatives
12/24/1996CA2176998A1 Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same
12/24/1996CA2030174C Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
12/24/1996CA1338808C Cyclic amine compound
12/23/1996CA2179696A1 Coated food
12/23/1996CA2179679A1 Substituted benzothiazine derivative
12/23/1996CA2179105A1 Antioxidant grafted polysaccharides and their uses
12/20/1996CA2179426A1 Use of ligands specific to rxr receptors
12/20/1996CA2179205A1 Benzisothiazolyl-substituted aminomethylchromans
12/19/1996WO1996041185A1 Methods and compositions for binding endotoxins
12/19/1996WO1996040997A1 Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans
12/19/1996WO1996040982A1 Therapeutic inhibition of phospholipase a2 in neurodegenerative disease
12/19/1996WO1996040963A1 Cationic lipid:dna complexes for gene targeting
12/19/1996WO1996040961A1 Peptide-enhanced cationic lipid transfections
12/19/1996WO1996040954A1 Oral delivery of adeno-associated viral vectors
12/19/1996WO1996040930A1 Mutants of streptococcal toxin a and methods of use
12/19/1996WO1996040915A2 Novel ctla4/cd28 ligands and uses therefor
12/19/1996WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996WO1996040908A1 OLIGONUCLEOTIDES SPECIFIC FOR CYTOKINE SIGNAL TRANSDUCER gp130 mRNA
12/19/1996WO1996040906A1 Optimized minizymes and miniribozymes and uses thereof
12/19/1996WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996WO1996040898A1 Triple-helix forming oligonucleotides for targeted mutagenesis
12/19/1996WO1996040868A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996WO1996040863A1 Conversion of compactin to pravastatin by actinomadura
12/19/1996WO1996040771A1 SINGLE CHAIN ANALOGS OF THE TGF-β SUPERFAMILY (MORPHONS)
12/19/1996WO1996040746A1 Lysyloxidase inhibitors
12/19/1996WO1996040745A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996WO1996040744A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa
12/19/1996WO1996040740A1 Peptide and method of obtaining it
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040728A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds
12/19/1996WO1996040727A1 Novel nor-pregnanes for inducing hypothalamic effects
12/19/1996WO1996040725A1 Phosphonic acid-based cationic lipids
1 ... 6844 6845 6846 6847 6848 6849 6850 6851 6852 6853 6854 6855 6856 6857 6858 6859 6860 6861 6862 6863 6864 ... 7860